By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Sunovion Pharmaceuticals Inc. 

84 Waterford Drive

Marlborough  Massachusetts  01752  U.S.A.
Phone: 508-481-6700 Fax:


SEARCH JOBS


Industry
Pharmaceutical


Collaborations

Acadia  ACADIA has formed a broad CNS collaboration with Sepracor for the discovery and development of new drug candidates against muscarinic receptors.

Cubist 





Company News
Sunovion’s Latuda (Lurasidone HCI) Receives Health Canada Approval To Treat Adolescents With Schizophrenia 7/21/2017 10:33:03 AM
Sunovion Expands Commitment To Building Stronger Communities Through Partnerships With The Red Sox Foundation, United Way Of Tri-County And Bergen Volunteer Center 7/18/2017 11:05:11 AM
Sunovion Enters Agreement To Divest Asthma And Allergy Products To Covis Pharma 7/13/2017 7:23:53 AM
Sunovion Announces FDA Acceptance For Review Of New Drug Application Resubmission For SUN-101/Eflow (Glycopyrrolate) For The Treatment Of Chronic Obstructive Pulmonary Disease (COPD) 6/30/2017 7:57:17 AM
Sunovion Announces FDA Acceptance For Review Of Supplemental New Drug Application For Latuda (Lurasidone HCI) For The Treatment Of Bipolar Depression In Children And Adolescents 6/30/2017 7:38:41 AM
PsychoGenics Achieves A Milestone In Drug Discovery Collaboration With Sunovion 6/13/2017 7:50:34 AM
FDA Rejects Sunovion's COPD NDA For SUN-101/eFlow 5/30/2017 6:39:27 AM
Sunovion Announces Positive Results From Pivotal Study Evaluating Novel Drug Candidate Dasotraline In Adults With Binge Eating Disorder At Annual American Psychiatric Association Meeting 5/24/2017 6:35:51 AM
Sunovion Presents Phase III Data Showing Safety, Efficacy And Improvement In Quality Of Life Outcomes In Patients With Moderate-To-Very Severe Chronic Obstructive Pulmonary Disease Treated With SUN-101/Eflow (Glycopyrrolate) 5/23/2017 8:57:57 AM
Sunovion Announces Utibron Neohaler (Indacaterol/Glycopyrrolate) Inhalation Powder Data Showing Lung Function And Health-Related Quality Of Life Improvement In Patients With Moderate-To-Severe Chronic Obstructive Pulmonary Disease 5/23/2017 8:46:30 AM
12345678910...
//-->